Application 209872
- Type
- ANDA
- Sponsor
- STI PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 25MG | No | No |
| 002 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | CAPSULE;ORAL | 50MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209872-001 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | |
| A209872-002 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209872-001 | AB |
| A209872-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A209872-001 | CYCLOPHOSPHAMIDE | 25MG | CAPSULE / ORAL | AB | 2018-05-07 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A209872-002 | CYCLOPHOSPHAMIDE | 50MG | CAPSULE / ORAL | AB | 2018-05-07 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209872-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A209872-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A209872-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209872-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209872-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209872-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209872-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209872-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209872-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209872-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209872-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209872-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209872-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209872-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209872-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209872-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209872-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209872-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209872-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209872-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209872-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209872-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209872-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209872-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209872-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209872-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209872-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209872-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209872-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209872-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209872-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209872-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209872-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209872-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A209872-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A209872-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A209872-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A209872-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A209872-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A209872-002 | AB | 1 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cyclophosphamide | CYCLOPHOSPHAMIDE FOR INJECTION | Hainan Poly Pharm. Co., Ltd. | 6fde2705-a2d8-4d48-9618-b9d99d051373 | 2025-01-03 | Warnings, Adverse reactions | Cyclophosphamide |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Sandoz Inc | cf2f4b95-0327-499a-a5a3-51b1bdef68c5 | 2024-12-30 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | XGen Pharmaceuticals DJB, Inc. | 02e64046-687d-449e-e063-6294a90a6c32 | 2024-12-20 | Warnings, Adverse reactions | CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Alembic Pharmaceuticals Limited | 9e699cf7-860e-4c03-9760-0c24d56df2de | 2024-12-16 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Alembic Pharmaceuticals Inc. | 3d6e68b1-5120-4cbb-a9d2-fb09d1b74ea1 | 2024-12-10 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | NorthStar Rx LLC | 76f057be-e3da-0a89-e053-2a91aa0a8438 | 2024-11-20 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Hikma Pharmaceuticals USA Inc. | 8135b917-882f-4b4c-99b7-fa8ea54af4bf | 2024-11-19 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Fresenius Kabi USA, LLC | 31986d36-a1bf-4903-93a4-ce7386241ba1 | 2024-10-09 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Avyxa Pharma, LLC | 6f593585-e0dd-48bc-bd2b-c6c787e0b98c | 2024-07-26 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| Cyclophosphamide | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | Baxter Healthcare Company | 34dbffee-80e0-49c3-90e8-95713a0b7fbe | 2024-04-10 | Warnings, Adverse reactions | Cyclophosphamide |
| Cyclophosphamide | CYCLOPHOSPHAMIDE | Baxter Healthcare Corporation | 769ded74-6186-40a8-8e44-ceff67287451 | 2020-08-07 | Warnings, Adverse reactions | Cyclophosphamide CYCLOPHOSPHAMIDE |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | Baxter Healthcare Company | cef038cc-efab-46d9-99c2-95bb11d6c9bc | 2017-03-15 | Warnings, Adverse reactions | CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | Baxter Healthcare Company | 6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe | 2017-03-15 | Warnings, Adverse reactions | CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-021 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |
| 54879-022 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | STI Pharma LLC | ANDA | Current |